microRNA 548e (miR-548e)

microRNA 548e (miR-548e) is an endogenous, short, non-coding RNA molecule belonging to the miR-548 family, a group of microRNAs involved in post-transcriptional regulation of gene expression through binding to complementary sequences in target mRNAs, leading to their degradation or translational repression. The miR-548 family is generally poorly conserved and exhibits context-dependent roles in various biological processes, especially in cancer, where different members can function as tumor suppressors or oncogenes depending on tissue and disease context[1][3]. The best-characterized functions are described for other family members (e.g., miR-548m), including roles in epithelial–mesenchymal transition, cell migration, and cancer metastasis suppression[1]. Specific functional and mechanistic data for miR-548e itself are not available in major referenced databases or the literature currently found, making its precise disease associations and therapeutic targeting unclear. Clarification: - While "miR-548 family" members are extensively referenced in cancer biology, miR-548e specifically lacks direct experimental characterization or association with validated therapeutic targets and drugs in current public literature or curated databases. Available descriptions focus on the general function of microRNAs and the diversity within the miR-548 family[1][3]. - It is not a therapeutic target in the classic sense (e.g., receptor, enzyme, transporter); rather, it is a regulatory non-coding RNA participating in gene expression modulation. - The entry "is_incorrect: true" is flagged because there is insufficient evidence to treat "microRNA 548e" as a canonical, experimentally validated therapeutic target. No major information is missing, but the target class is often misunderstood in clinical pharmacology settings.

Other names

hsa-mir-548eMIRN548EMIR548E